Both drugs depend on the same liver enzymeCYP3A4to be broken down
Im in the Chicago area
Clinical Trial Evidence for Wegovy Wegovy approval was supported by large, randomized clinical trials, including the STEP 1 study: 1,961 adults with obesity or overweight plus weight-related health conditions 68-week study duration Average weight loss of approximately 14.9% of body weight 86% of participants lost at least 5% of body weight 69% lost at least 10% 50% lost at least 15% Participants followed reduced-calorie diets and increased physical activity Before receiving FDA approval, GLP-1 medications completed Phase I, Phase II, and Phase III trials
It's a collective pacing strategy dictated by physiology, not just tactics
When eating, your digestive system breaks down carbohydrates into simple sugars that enter your bloodstream
Together, they act as coenzymes in energy production, nervous system function, and cell growth